Patients should review their individual state plans formulary or contact their case manager for current details
8,129,343 (343) and 8,536,122 (122)
Primary care physicians will likely need education and training focused on this new class of medications, given a shortage of endocrinologists and obesity medicine specialists. Lee and colleagues noted there were study limitations, such as a lack of data on prescription indication, including whether it was used off-label. However, the increase in dispensing of injectable semaglutide for weight management suggests increasing use for this indication, they wrote
GLP-1 receptor agonists like Semaglutide and Tirzepatide (a newer dual-acting drug) work by activating GLP-1 receptors, thereby amplifying its effects on insulin, appetite suppression, and digestion